Fig. 2From: Impact of ITPA gene polymorphism for predicting anemia and treatment outcome in HCV infected patients taking Sofosbuvir Ribavirin therapyITPA rs1127354, rs7270101 genotype wise presentation of SVR achievers and relapsed HCV patients receiving Sofosbuvir ribavirin. Sustained Viral response (SVR)Back to article page